Premium
A PHASE I TRIAL OF 19‐28Z CAR‐T CELLS POST‐HIGH DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION (HDT‐ASCT) FOR RELAPSED AND REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL)
Author(s) -
Sauter C.,
Riviere I.,
Senechal B.,
Ni A.,
Bernal Y.,
Wang X.,
Purdon T.,
Hall M.,
Moskowitz C.,
Giralt S.,
Matasar M.,
Curran K.,
Park J.,
Sadelain M.,
Brentjens R.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_128
Subject(s) - medicine , diffuse large b cell lymphoma , gastroenterology , salvage therapy , cytokine release syndrome , surgery , lymphoma , oncology , chemotherapy , cancer , chimeric antigen receptor , immunotherapy